Cargando…
Efficacy of a feed additive consisting of nicarbazin (Coxar(®)) for use in turkeys for fattening (Huvepharma N.V.)
Following a request from the European Commission, the Panel on Additives and Products or substances used in Animal Feed (FEEDAP Panel) was asked to deliver a scientific opinion on the efficacy of the coccidiostat nicarbazin (Coxar(®)) when used in feed for turkeys for fattening. On the basis of the...
Autores principales: | Bampidis, Vasileios, Azimonti, Giovanna, Bastos, Maria de Lourdes, Christensen, Henrik, Dusemund, Birgit, Fašmon Durjava, Mojca, Kouba, Maryline, López‐Alonso, Marta, López Puente, Secundino, Marcon, Francesca, Mayo, Baltasar, Pechová, Alena, Petkova, Mariana, Ramos, Fernando, Sanz, Yolanda, Villa, Roberto Edoardo, Woutersen, Ruud, Gropp, Jürgen, Rychen, Guido, Holczknecht, Orsolya, Vettori, Maria Vittoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864502/ https://www.ncbi.nlm.nih.gov/pubmed/35228851 http://dx.doi.org/10.2903/j.efsa.2022.7162 |
Ejemplares similares
-
Safety for the environment of a feed additive consisting of nicarbazin (Coxar(®)) for use in turkeys for fattening (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2021) -
Safety and efficacy of Coxar(®) (nicarbazin) for turkeys for fattening
por: Rychen, Guido, et al.
Publicado: (2018) -
Efficacy of the feed additive consisting of amprolium hydrochloride (COXAM
(®)) for use in chickens for fattening and chickens reared for laying (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2021) -
Safety of a feed additive consisting of halofuginone hydrobromide (STENOROL®) for chickens for fattening and turkeys (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2022) -
Safety and efficacy of a feed additive consisting of halofuginone hydrobromide (STENOROL®) for chickens for fattening and turkeys for fattening/reared for breeding (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2023)